Pharmafile Logo
Pharmafocus logo
Advanced Search
sharapova

Seven quick facts about meldonium – and why it will get Sharapova banned

March 10, 2016
Medical Communications, Research and Development 7 things, anti-doping, banned, maria sharapova, medlonum, reasons, susbtance

It’s made world headlines this week, but the drug meldonium would have been unknown to many before it emerged that …

Feature
angiochip

Engineers create lab-grown heart and liver tissue for drug testing and discovery

March 10, 2016
Manufacturing and Production, Research and Development 3D, angiochip, artificial heart, drug delivery, innovation, liver, vessels

Researchers at University of Toronto have developed “person-on-a-chip” technology which sees the growing of realistic human tissues outside the body. …

News
genmab

Genmab Darzalex success triggers second milestone payment

March 10, 2016
Research and Development, Sales and Marketing Genmab, Janssen, daratumumab, darzalex, follicular lymphoma

Genmab says it has reached a $5 million milestone in its daratumumab collaboration with Janssen as a result of success …

News
valeant

Valeant ends controversial litigation with R&O Pharmacy

March 10, 2016
Litigation, Philidor, Valeant, controversy, r&o pharmacy, scandal

Valeant has announced that, in conjunction with R&O Pharmacy, its has jointly requested that the Court dismiss the litigation between …

News
wkd_logo

Tackling Chronic Kidney Disease – early action will aid prevention this World Kidney Day 2016

March 10, 2016
Medical Communications, Research and Development

Today (10th March) marks World Kidney Day 2016. Now in its 11th year, it is the largest such event focused …

Feature
dr_amit_nathwani

Sanofi appoints Novartis executive Dr Ameet Nathwani executive VP and CMO

March 10, 2016
Medical Communications

Sanofi has announced the appointment of Dr Ameet Nathwani as a new member of its Executive Committee, and to the …

Appointment
anna_cmo

Rigel names Anne-Marie Duliege chief medical officer

March 9, 2016
Medical Communications

Biotech firm Rigel Pharmaceuticals (Nasdaq: RIGL) named Anne-Marie Duliege its chief medical officer, replacing Elliott Grossbard, who is retiring.Dr Grossbard will remain …

Appointment
shire_image_4

Shire launches long-acting ADHD drug in UK

March 9, 2016
Sales and Marketing ADHD, Shire

Shire has launched its long-acting ADHD drug Intuniv (guanfacine) in the UK, for children and adolescents aged 6-17. The treatment …

News
pfizer_building

Pfizer enters $5 billion share buyback deal with Goldman Sachs

March 9, 2016
Business Services, Research and Development Pfizer, Share buyback, Stock, markets

US drug major Pfizer (NYSE: PFE) on Wednesday said it has entered into an accelerated share repurchase agreement with Goldman, …

News
abpi_reception_close_7

Pharma industry’s contribution to NHS medicines bill tops £1 billion

March 9, 2016
Manufacturing and Production, Medical Communications, Research and Development ABPI, PPRS, goodwill, pharma industry

The pharmaceutical industry has now contributed over £1 billion to the Department of Health towards the cost of new medicines …

News

Late-stage Pfizer drug study shows significant reduction in haemophilia B bleeding

March 9, 2016
Research and Development BeneFIX, Pfizer, haemophilia B

Pfizer on Wednesday said late-stage trials for its drug candidate to treat haemophilia B showed prophylactic use resulted in significant reduction …

News

TiGenix says additional data for stem cell product affirms safety profile

March 9, 2016
Research and Development Crohn’s disease, TiGenix, crohn's disease, drug trial

Belgian biotech firm TiGenix said the results of a 52-week follow-up study of its trial drug for a stem-cell condition …

News
karl_ludwig_kley

Merck chief executive Karl-Ludwig Kley to step down in April

March 9, 2016
Medical Communications, Research and Development Denreon, Karl-Ludwig Kley, Merck, karl ludwig kley

 It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …

Appointment
biotrial_facility_rennes

French clinical trial tragedy “astonishing and unprecedented”, says report

March 9, 2016
Medical Communications, Research and Development Bial, Biotrial, France, clinical trial, death, rennes, tragedy

A report into the clinical trial tragedy in France in January has called the event “astonishing and unprecedented” but did …

News
peptimimesis

Ipsen and PeptiMimesis announce oncology research partnership

March 9, 2016
Research and Development INSERM, PeptiMimesis, ipsen, peptides

Specialist pharma company Ipsen is partnering with French start-up PeptiMimesis to develop and market of novel therapeutic peptides in oncology. …

News
clinical_trial

Crown Bioscience expands portfolio with PreClinOmics acquisition

March 9, 2016
Manufacturing and Production, Research and Development cardiovascular, collaboration, crown bioscience, metabolic, preclinomics

Crown Bioscience has announced the acquisition of PreClinOmics, which will see the US-based drug discovery solutions company expand its cardiovascular …

News
merckincweb2

MSD joins charity-industry partnership Dementia Consortium

March 9, 2016
Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium

The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …

News
medimmune_logo_on_building

AZ drug gets orphan status for rare inflammatory disease

March 9, 2016
Research and Development AstraZeneca, MEDI-551, MedImmune, orphan drug

AstraZeneca’s biologics R&D arm MedImmune has been granted Orphan Drug Designation by the FDA for its investigational anti-CD19 monoclonal antibody, …

News

Genmab ends ofatumumab trials for autoimmune conditions; to focus on multiple sclerosis

March 9, 2016
Research and Development Arzerra, GSK

Danish drug-company Genmab (Nasdaq Copenhagen: GEN) said it will discontinue the late-stage trials for Arzerra (ofatumumab) to develop a treatment for …

News

Medimmune gets US FDA fast track designation for flu drug

March 9, 2016
Research and Development

UK drug major AstraZeneca (LSE: ANZ) said its biologics R&D unit, MedImmune, has received Fast Track designation from the US …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026